Head-to-head
Hims & Hers vs Ro (2026)
Pricing, medications, clinical support, and our verdict on which fits which reader.
Last verified: · by The GLP Report Editorial Team
TL;DR verdict
Better for lowest 12-month cost
Hims & Hers
Better for clinical support
Ro
Quick compare
| Criterion | Hims & Hers | Ro |
|---|---|---|
| Starting price (month 1) | $199/mo | $145/mo |
| Maintenance monthly price | $249/mo | $445/mo |
| 12-month true total | $2,938 | $5,340 |
| Medications offered | Compounded Semaglutide (injection), Brand-name Wegovy (via Novo Nordisk partnership), Oral GLP-1 blend | Compounded Semaglutide, Compounded Tirzepatide, Brand-name Wegovy / Zepbound (when clinically indicated) |
| FDA-approved options available | Yes | Yes |
| Compounded options available | Yes | Yes |
| Consultation format | Asynchronous | Hybrid |
| States served | All 50 states | All 50 states |
| Coaching included | Available as add-on | Included |
| Cancellation policy | Monthly, no long-term contract; cancel any time via the app | Monthly membership; cancel any time, unused medication is non-refundable |
| Prescription turnaround (SLA) | See provider review | See provider review |
| Lab work required | See provider review | See provider review |
| Customer support hours | See provider review | See provider review |
| Trustpilot score | 4.3 / 5 (28,500 reviews) | 4.1 / 5 (9,800 reviews) |
| FDA warning letter history | Received 2025-09-12 · resolved | Received 2025-09-12 · resolved |
Choose Hims & Hers if…
- Readers who want brand recognition and a polished app experience
- Readers looking for FDA-approved Wegovy via the Novo Nordisk partnership
- Members who value mobile-first refills and quick re-consults
Choose Ro if…
- Readers who want meaningful human clinical support, not just a refill engine
- Readers who value structured coaching and habit-based programming
- Members who have flexed off compounded options and want a serious program
Regulatory & risk snapshot
Regulatory & risk snapshot
FDA warning letter: Received 2025-09-12; resolved.September 2025 letter cited marketing claims on compounded semaglutide messaging. Hims & Hers revised advertising language in Q4 2025; FDA acknowledged resolution. Surface this history in the Regulatory & Risk Snapshot section of the provider review.
Class action status: None active on record.
Regulatory & risk snapshot
FDA warning letter: Received 2025-09-12; resolved.Part of the September 2025 cohort of letters to GLP-1 telehealth providers. Ro revised compounded-medication claims and the letter was marked resolved in Q4 2025. Include in the Regulatory & Risk Snapshot; do not minimize.
Class action status: None active on record.
Common side effects
GLP-1 medications carry a recognized side-effect profile. Reported effects include:
- Gastrointestinal (GI) symptoms — nausea, vomiting, diarrhea, constipation; most common during titration.
- Pancreatitis risk — discontinue and seek care if you develop persistent severe abdominal pain.
- Thyroid concerns — these medications carry a boxed warning for thyroid C-cell tumors observed in rodents.
- Other reported effects — gallbladder disease, kidney injury (often dehydration-mediated), injection-site reactions, and hypoglycemia (especially with insulin or sulfonylurea use).
This list is not exhaustive. Individual results vary; clinical-trial outcomes may not reflect typical user experience. Discuss your full medical history with a qualified healthcare professional before starting treatment.
Who should not take GLP-1 medications
GLP-1 medications are not appropriate for everyone. You should not start treatment if any of the following apply:
- Personal or family history of medullary thyroid cancer (MTC).
- Personal or family history of multiple endocrine neoplasia type 2 (MEN 2).
- Current pregnancy, planned pregnancy, or breastfeeding — discontinue at least two months before a planned pregnancy.
- Known hypersensitivity to semaglutide, tirzepatide, or any inactive ingredient in the product.
- Prior history of pancreatitis (relative contraindication — discuss with your prescribing clinician).
This list summarizes the labeled contraindications and is not a substitute for medical evaluation. A qualified healthcare professional must review your history before any prescription is issued.
Frequently asked questions
- Which is cheaper over 12 months — Hims & Hers or Ro?
- Hims & Hers is cheaper over 12 months. Hims & Hers totals $2,938; Ro totals $5,340.
- Do Hims & Hers and Ro offer FDA-approved medications?
- Hims & Hers: Yes. Ro: Yes.
- Can I switch from Hims & Hers to Ro?
- Switching providers is typically straightforward — both programs are month-to-month and do not lock members into annual contracts. Keep in mind that changing medication or dose should involve your clinician, and that any unused medication already shipped is generally non-refundable.